Correlates of metabolic abnormalities in bipolar I disorder at initiation of acute phase treatment

Psychiatry Investigation

Volumn 6, Issue 2, 2009, Pages 78-84

  Kim, Byungsu ^a   Kim, Sangeok ^a   McIntyre, Roger S ^b   Hui, Joon Park ^c   Seong, Yoon Kim ^a   Yeon, Ho Joo ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b UNIVERSITY OF TORONTO   (Canada)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Bipolar disorder; Hypercholesterolemia; Hyperglycemia; Obesity

Indexed keywords

AMFEBUTAMONE; ANTIDIABETIC AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CHOLESTEROL; CLOZAPINE; GLUCOSE; HALOPERIDOL; HYPOCHOLESTEROLEMIC AGENT; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; ZIPRASIDONE;

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; BIPOLAR I DISORDER; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DEMOGRAPHY; DEPRESSION; DIABETES MELLITUS; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MANIA; METABOLIC DISORDER; MOOD DISORDER; OBESITY; PREVALENCE; TREATMENT PLANNING;

EID: 67651152991     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2009.6.2.78     Document Type: Article

References (33)

1. Elmslie JL, Mann JI, Silverstone JT, Williams SM, Romans SE. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001;62:486-491; quiz 492-493.
2. Elmslie JL, Silverstone JT, Mann JI, Williams SM, Romans SE. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000;61:179-184.
3. Fagiolini A, Frank E, Houck PR, Mallinger AG, Swartz HA, Buysse DJ, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002;63:528-533. (Pubitemid 34680363)
4. Fagiolini A, Kupfer DJ, Houck PR, Novick DM, Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003;160:112-117. (Pubitemid 36042434)
5. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003;289:76-79.
6. Lilliker SL. Prevalence of diabetes in a manic-depressive population. Compr Psychiatry 1980;21:270-275.
7. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156:1417-1420. (Pubitemid 29416540)
8. Regenold WT, Thapar RK, Marano C, Gavimeni S, Kondapavuluru PV. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002;70:19-26. (Pubitemid 34756609)
9. Horrobin DF, Bennett CN. Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 1999;60:217-234.
10. Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Bayik Y. Serum leptin and cholesterol levels in patients with bipolar disorder. Neuropsychobiology 2002;46:176-179. (Pubitemid 36173364)
11. Sobczak S, Honig A, Christophe A, Maes M, Helsdingen RW, De Vriese SA, et al. Lower high-density lipoprotein cholesterol and increased omega-6 polyunsaturated fatty acids in first-degree relatives of bipolar patients. Psychol Med 2004;34:103-112.
12. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005;7:424-430. (Pubitemid 41419409)
13. Cardenas J, Frye MA, Marusak SL, Levander EM, Chirichigno JW, Lewis S, et al. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008;106:91-97.
14. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-689. (Pubitemid 32893993)
15. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419. (Pubitemid 36935533)
16. Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssönen K, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 2006;37:806-811.
17. Ruzickova M, Slaney C, Garnham J, Aida M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry 2003;48:458-461. (Pubitemid 37295203)
18. Henderson DC. Managing weight gain and metabolic issues in patients treated with atypical antipsychotics. J Clin Psychiatry 2008;69:e04.
19. Kim B, Kim SJ, Son JI, Joo YH. Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients. J Affect Disord 2008;105:45-52. (Pubitemid 350236344)
20. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P, Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. World Rev Nutr Diet 2005;94:1-12.
21. McElroy SL, Frye MA, Suppes T, Dhavale D, Keck PE Jr, Leverich GS, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207-213. (Pubitemid 34407079)
22. Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, et al. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 2008;106:197-201. (Pubitemid 350309669)
23. Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry 2008;30:318-323. (Pubitemid 351863767)
24. van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A, et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord 2008;10:342-348. (Pubitemid 351637699)
25. Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008;10:607-616. (Pubitemid 352003828)
26. Straker D, Correll CU, Kramer-Ginsberg E, Abdulhamid N, Koshy F, Rubens E, et al. Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications. Am J Psychiatry 2005;162:1217-1221. (Pubitemid 40770711)
27. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999;84:2329-2335. (Pubitemid 30670857)
28. Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab 2004;89:2750-2755. (Pubitemid 38766361)
29. Fagiolini A, Chengappa KN, Soreca I, Chang J. Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden. CNS Drugs 2008;22:655-669. (Pubitemid 351950097)
30. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469-480.
31. Morriss R, Mohammed FA. Metabolism, lifestyle and bipolar affective disorder. J Psychopharmacol 2005;19:94-101. (Pubitemid 44567863)
32. Mackin P, Watkinson HM, Young AH. Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study. Diabetologia 2005;48:215-221. (Pubitemid 40543292)
33. Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E, et al. Atypical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord 2007;98:247-252. (Pubitemid 46151723)